Insider · CIK 0001744749
Jonathan Biller
Files at VRTX (VERTEX PHARMACEUTICALS INC / MA). First filing Feb 12, 2025, latest Feb 26, 2026.
Jonathan Biller files SEC Form 4 as officer at VRTX (VERTEX PHARMACEUTICALS INC / MA). Since Feb 12, 2025, Jonathan Biller has reported 0 open-market buys worth $0 and 8 open-market sells worth $6.4M, the latest filed on Feb 26, 2026.
A track record needs three past buys with six months of prices behind them; Jonathan Biller has 0, so none is measured yet.
The newest scored trade: sold $460k of VRTX on Feb 25, 2026, filed Feb 26, 2026, scored 27 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 5 sells worth $3.8M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
VRTX: VERTEX PHARMACEUTICALS INC / MA
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 27Weak | VERTEX PHARMACEUTICALS INC / MA | $460k 945 shares | -6% | +32% from low-6% from high | |
| 40Moderate | VERTEX PHARMACEUTICALS INC / MA | $1.8M 3,720 shares | -19% | +30% from low-7% from high | |
| 28Weak | VERTEX PHARMACEUTICALS INC / MA | $493k 988 shares | -6% | +34% from low-4% from high | |
| 33Weak | VERTEX PHARMACEUTICALS INC / MA | $886k 1,925 shares | -8% | +26% from low-10% from high | |
| 21Weak | VERTEX PHARMACEUTICALS INC / MA | $156k 347 shares | -2% | +26% from low-10% from high | |
| 9Weak | VERTEX PHARMACEUTICALS INC / MA | $281k 694 shares | -4% | +12% from low-21% from high | |
| 32Weak | VERTEX PHARMACEUTICALS INC / MA | $754k 1,657 shares | -9% | +17% from low-11% from high | |
| 40Moderate | VERTEX PHARMACEUTICALS INC / MA | $1.6M 3,433 shares | -17% | +15% from low-12% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Dec 3, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | 347 0.00% of outstanding | $156k | Dec 3, 2025 | $281k |
| Oct 2, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | 694 0.00% of outstanding | $281k | Oct 2, 2025 | none |
| Feb 18, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | 1,657 0.00% of outstanding | $754k | Feb 18, 2025 | $1.6M |
| Feb 11, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | 3,433 0.00% of outstanding | $1.6M | Feb 11, 2025 | none |
Transactions
Every row this insider has filed, 21 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 24, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | FTax withholding Common Stock10b5-1 | -1,144 | $485.11 | $555k | 14,604 | Feb 26, 2026 |
| Feb 25, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | SOpen-market sale Common Stock10b5-1 | -945 | $486.35 | $460k | 13,659 | Feb 26, 2026 |
| Feb 17, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | AGrant or award Common Stock10b5-1 | +4,135 | $0.00 | $0 | 20,973 | Feb 19, 2026 |
| Feb 17, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | FTax withholding Common Stock10b5-1 | -1,505 | $483.75 | $728k | 19,468 | Feb 19, 2026 |
| Feb 17, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | SOpen-market sale Common Stock10b5-1 | -2,476 | $489.46 | $1.2M | 16,992 | Feb 19, 2026 |
| Feb 18, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | SOpen-market sale Common Stock10b5-1 | -1,244 | $473.68 | $589k | 15,748 | Feb 19, 2026 |
| Feb 13, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | FTax withholding Common Stock10b5-1 | -2,993 | $487.76 | $1.5M | 17,826 | Feb 18, 2026 |
| Feb 13, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | SOpen-market sale Common Stock10b5-1 | -988 | $499.00 | $493k | 16,838 | Feb 18, 2026 |
| Feb 10, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | FTax withholding Common Stock10b5-1 | -1,630 | $468.41 | $764k | 22,744 | Feb 12, 2026 |
| Feb 11, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | SOpen-market sale Common Stock10b5-1 | -1,925 | $460.43 | $886k | 20,819 | Feb 12, 2026 |
| Jan 22, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | AGrant or award Common Stock | +6,294 | $0.00 | $0 | 21,600 | Jan 26, 2026 |
| Jan 22, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | AGrant or award Common Stock | +2,774 | $0.00 | $0 | 24,374 | Jan 26, 2026 |
| Dec 3, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | SOpen-market sale Common Stock10b5-1 | -347 | $449.00 | $156k | 15,306 | Dec 5, 2025 |
| Oct 1, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | FTax withholding Common Stock10b5-1 | -1,259 | $400.00 | $504k | 16,347 | Oct 3, 2025 |
| Oct 2, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | SOpen-market sale Common Stock10b5-1 | -694 | $404.21 | $281k | 15,653 | Oct 3, 2025 |
| Feb 14, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | FTax withholding Common Stock10b5-1 | -1,504 | $463.46 | $697k | 19,263 | Feb 19, 2025 |
| Feb 18, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | SOpen-market sale Common Stock10b5-1 | -1,657 | $455.06 | $754k | 17,606 | Feb 19, 2025 |
| Feb 12, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | AGrant or award Common Stock | +4,437 | $0.00 | $0 | 20,767 | Feb 14, 2025 |
| Feb 10, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | FTax withholding Common Stock10b5-1 | -1,632 | $467.98 | $764k | 19,763 | Feb 12, 2025 |
| Feb 11, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | SOpen-market sale Common Stock10b5-1 | -3,433 | $459.87 | $1.6M | 16,330 | Feb 12, 2025 |
| Feb 4, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | AGrant or award Common Stock | +4,744 | $0.00 | $0 | 21,395 | Feb 6, 2025 |
Questions about Jonathan Biller
Answered from the filings on this page, as of the latest one.
Is Jonathan Biller buying or selling?
In the last 12 months Jonathan Biller reported 0 open-market buys worth $0 and 5 open-market sells worth $3.8M on SEC Form 4; the latest was sold $460k of VRTX on Feb 25, 2026. Grants, option exercises and tax withholding are not counted.
How did Jonathan Biller's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jonathan Biller has 0.
Where does Jonathan Biller file Form 4?
Jonathan Biller has filed Form 4 at VRTX (VERTEX PHARMACEUTICALS INC / MA) as EVP and Chief Legal Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.